Open Access

From clinical trial to clinical recommendations: how to apply evidence into practice?

Congress Session

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
20 presentations
0 follower

4 more presentations in this session

Introduction: how NOACs changed the practice in cancer-associated thrombosis

Speaker: Professor S. Konstantinides (Mainz, DE)

Thumbnail

Beyond real word evidence: learnings from databases and registers

Speaker: Associate Professor J. Beyer-Westendorf (Dresden, DE)

Thumbnail

Translating guidelines into clinical practice: when to use NOAC or LMWH?

Speaker: Associate Professor P. Verhamme (Leuven, BE)

Thumbnail

Closing remarks

Speaker: Professor R. Bauersachs (Frankfurt am Main, DE)

Thumbnail

Access the full session

NOACs in cancer associated thrombosis: managing anticoagulation in cancer patients in clinical practice

Speakers: Doctor J. Weitz, Professor S. Konstantinides, Associate Professor J. Beyer-Westendorf, Associate Professor P. Verhamme, Professor R. Bauersachs
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

Open Access

A patient with NSTEMI and atrial fibrillation: how to implement the guidelines and take-home message.

27 August 2021

Open Access

A patient with NSTEMI and atrial fibrillation: what do the guidelines say?

27 August 2021

Open Access

Net clinical benefit of direct oral anticoagulants in very elderly and high bleeding risk patients with atrial fibrillation who are often excluded from oral anticoagulation therapy: a nationwide popul

27 August 2021

This platform is supported by

logo Novo Nordisk